Blood Drug Testing

H Pylori Breath Test News

Poster Presentation at Digestive Disease Week (DDW) Demonstrates Potential Application of Exalenz Bioscience’s ...Thursday, June 2, 2011 @ 10:55AMWILMINGTON, Del.--(BUSINESS WIRE)--Exalenz Bioscience announces that clinical study data has shown the potential of the BreathID® Breath Test System to measure gastric emptying rate as an alternative to invasive gastric scintigraphy.

Deadly Cancer Remains OverlookedFriday, May 27, 2011 @ 9:15AMFT. LAUDERDALE, Fla. -- In the lead-up to the American Society of Clinical Oncology Annual Meeting, the largest gathering of cancer experts in the world, a recent survey reports that 95 percent of U.S. adults do not think of "stomach cancer" first when presented with a list of the common symptoms of stomach cancer, the second deadliest cancer in the world.

Potential Application of Exalenz Bioscience’s BreathID® Breath Test System in Diagnosing Chronic Pancreatitis ...Wednesday, May 25, 2011 @ 8:19AMWILMINGTON, Del.--(BUSINESS WIRE)--Exalenz Bioscience, Ltd., announced that a pilot study presented at DDW shows the potential clinical utility of the BreathID® System and 13C-di-peptide substrate in evaluating pancreatic function

Soul foodMonday, April 4, 2011 @ 1:39PMUlcers: the burning discomfort, your diet is important

Exalenz losses pile upMonday, August 30, 2010 @ 6:00PMSince its founding, diagnostics technology developer Exalenz Bioscience has racked up NIS 85 million in losses, including the NIS 5.7 million loss it posted this week for the second quarter of 2010. Yet the red ink does not seem to be deterring controlling shareholder Moshe (Mori ) Arkin, who has continued to build up his holdings in the company.

Exalenz signs 3rd US distribution deal for H. pylori testTuesday, July 13, 2010 @ 7:38AMThe agreement is for distribution of the company’s diagnostic devices among gastroenterologists.

Roy Exum: Why Ulcers Went AwayMonday, May 24, 2010 @ 5:58AMf … and when … healthcare reform ever actually comes to pass, the nation’s lawmakers should put a sharp-toothed rule into effect that would require every doctor’s office to have good and current magazines in the waiting rooms.

Paladin Labs Announces Amendment to R&D Agreement With Isotechnika Pharma Inc.Thursday, February 18, 2010 @ 6:13AMMONTREAL, CANADA -- (Marketwire - Feb. 18, 2010) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, today announced that it has agreed to amendments to its existing agreements with Isotechnika Pharma Inc. (TSX: ISA) that will give Paladin the full share of future net profits of the Isodiagnostika line of diagnostic products in exchange for an undisclosed lump sum ...

Paladin Labs Announces Amendment to R&D Agreement With Isotechnika Pharma Inc.Thursday, February 18, 2010 @ 6:01AMMONTREAL, CANADA -- - Paladin Labs Inc. , a leading Canadian specialty pharmaceutical company, today announced that it has agreed to amendments to its existing agreements with Isotechnika Pharma Inc. that will give Paladin the full share of future net profits of the Isodiagnostika line of diagnostic products in exchange for an undisclosed lump sum payable over the next twelve months.